Replies to post #346 on Oxford BioMedica PLC (OXBDF)

[georgejjl]

The new improved ProSavin trial about to start and the latest news release stating the following:

The Group’s capabilities have resulted in partnerships including an initial three-year contract (with potential for extension) with Novartis under which the Group is the sole source of lentiviral vector clinical supply for Novartis’ CTL-019 programmes and a second undisclosed CAR-T programme, as well as being a key partner for vector manufacture process development.

http://www.oxfordbiomedica.co.uk/press-releases/oxford-biomedica-announces-mhra-gmp-manufacturing-approvals-and-completion-of-expansion-phase/


Why is the stock price down?

Good luck and GOD bless,

George